Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Equity Ratio: 2017-2021

Historic Equity Ratio for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to 0.92.

  • Cogent Biosciences' Equity Ratio rose 677.64% to 0.92 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.92, marking a year-over-year increase of 677.64%. This contributed to the annual value of 0.94 for FY2020, which is 45.53% up from last year.
  • According to the latest figures from Q3 2021, Cogent Biosciences' Equity Ratio is 0.92, which was down 1.66% from 0.93 recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Equity Ratio ranged from a high of 0.95 in Q1 2021 and a low of -1.41 during Q1 2018.
  • Its 3-year average for Equity Ratio is 0.65, with a median of 0.64 in 2019.
  • As far as peak fluctuations go, Cogent Biosciences' Equity Ratio tumbled by 132.06% in 2020, and later surged by 677.64% in 2021.
  • Over the past 5 years, Cogent Biosciences' Equity Ratio (Quarterly) stood at -0.99 in 2017, then surged by 170.49% to 0.70 in 2018, then fell by 8.32% to 0.64 in 2019, then spiked by 45.53% to 0.94 in 2020, then spiked by 677.64% to 0.92 in 2021.
  • Its last three reported values are 0.92 in Q3 2021, 0.93 for Q2 2021, and 0.95 during Q1 2021.